Biotech Values

[ghmm]

That is a pretty harsh (and IMO unfair) statement. If one is looking at it from strictly an investor standpoint perhaps you have a point. If however one is looking at it from the perspective of a parent of a child with a fatal/debilitating disease and NO treatment options its quite unfair. Their bar for efficacy in their case is much lower and your willingness to assume risk (that the efficacy is non-existent or even some level of safety risk) much greater. I would describe these people in other ways. Perhaps there is a sense of frustration and despair but I think its worth considering the situation these people are in before a generalized painting of them this way.